100 related articles for article (PubMed ID: 29477941)
1. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
2. Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis.
Mack EA; Dougher MC; Ginda AM; Cahill C; Murter M; Schell K; Tanhehco YC; Bhoj VG; Fesnak AD; Siegel DL; Kambayashi T; Aqui NA; O'Doherty U
Blood; 2024 Mar; 143(11):1049-1054. PubMed ID: 38052031
[TBL] [Abstract][Full Text] [Related]
3. Redefining hyperviscosity in acute leukemia: Potential implications for red cell transfusions in the microvasculature.
Musick JO; Williams EK; Fibben KS; Zhang DY; Caruso C; Sakurai Y; Tran R; Kemp ML; Lam WA
Am J Hematol; 2024 Jun; 99(6):1103-1107. PubMed ID: 38572662
[TBL] [Abstract][Full Text] [Related]
4. Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol.
Zeller B; Arad-Cohen N; Cheuk D; De Moerloose B; Navarro JMF; Hasle H; Jahnukainen K; Juul-Dam KL; Kaspers G; Kovalova Z; Jonsson OG; Lausen B; Munthe-Kaas M; Nystrom UN; Palle J; Pasauliene R; Pronk CJ; Saks K; Tierens A; Abrahamsson J
Haematologica; 2024 May; ():. PubMed ID: 38721737
[TBL] [Abstract][Full Text] [Related]
5. Management of hematological patients requiring emergency chemotherapy in the intensive care unit.
Lafarge A; Chean D; Whiting L; Clere-Jehl R; ;
Intensive Care Med; 2024 May; ():. PubMed ID: 38748265
[TBL] [Abstract][Full Text] [Related]
6. Differentiating Leukostasis From COVID-19 Pneumonia: Clinical and Radiological Perspectives for the Right Decision-Making.
Bouanani N; Abouchabaka I
Cureus; 2024 Mar; 16(3):e56708. PubMed ID: 38646395
[TBL] [Abstract][Full Text] [Related]
7. A 7-week-old male Golden Retriever with extreme leukocytosis: A case report.
Bingham E; Conner B; Stern J; Vitalo A; Schaer M
Clin Case Rep; 2020 Dec; 8(12):3498-3502. PubMed ID: 33363959
[TBL] [Abstract][Full Text] [Related]
8. Rapid Fire: Acute Blast Crisis/Hyperviscosity Syndrome.
Emerson G; Kaide CG
Emerg Med Clin North Am; 2018 Aug; 36(3):603-608. PubMed ID: 30037446
[TBL] [Abstract][Full Text] [Related]
9. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
Stahl M; Shallis RM; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukherjee S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
Leukemia; 2020 Dec; 34(12):3149-3160. PubMed ID: 32132655
[TBL] [Abstract][Full Text] [Related]
10. Evaluating measurable residual disease in acute myeloid leukemia.
Ravandi F; Walter RB; Freeman SD
Blood Adv; 2018 Jun; 2(11):1356-1366. PubMed ID: 29895626
[TBL] [Abstract][Full Text] [Related]
11. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP; Zeidan AM
Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
[TBL] [Abstract][Full Text] [Related]
12. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
Bewersdorf JP; Giri S; Tallman MS; Zeidan AM; Stahl M
Transfusion; 2020 Oct; 60(10):2360-2369. PubMed ID: 32776542
[TBL] [Abstract][Full Text] [Related]
13. Leukostasis in Chronic Lymphocytic Leukemia.
Singh N; Singh Lubana S; Dabrowski L; Sidhu G
Am J Case Rep; 2020 Jul; 21():e924798. PubMed ID: 32616708
[TBL] [Abstract][Full Text] [Related]
14. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
15. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis.
Lester TJ; Johnson JW; Cuttner J
Am J Med; 1985 Jul; 79(1):43-8. PubMed ID: 3860006
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children.
Bunin NJ; Kunkel K; Callihan TR
Med Pediatr Oncol; 1987; 15(5):232-5. PubMed ID: 3477680
[TBL] [Abstract][Full Text] [Related]
17. The factors influencing clinical outcomes after leukapheresis in acute leukaemia.
Lee H; Park S; Yoon JH; Cho BS; Kim HJ; Lee S; Kim DW; Chung NG; Cho B; Kim KB; Yoo J; Jekarl DW; Chae H; Lim J; Kim M; Oh EJ; Kim Y
Sci Rep; 2021 Mar; 11(1):6426. PubMed ID: 33742034
[TBL] [Abstract][Full Text] [Related]
18. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
[TBL] [Abstract][Full Text] [Related]
19. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis.
Göçer M; Kurtoğlu E
Ther Apher Dial; 2021 Oct; 25(5):697-703. PubMed ID: 33686785
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
